Table of Contents Table of Contents
Previous Page  4 / 33 Next Page
Information
Show Menu
Previous Page 4 / 33 Next Page
Page Background

Ovarian cancers in women with BRCA1/2

germline mutations are characterized by an

improved response to platinum-based

chemotherapy at first and subsequent relapses

and better outcomes (PFS, OS)

Defining BRCAness Phenotype

Tan JCO 2008

Tan D JCO 2008; Fong FC JCO 2010; Audeh MW Lancet 2010; Ledermann J Lancet 2014; Fong FC NEJM 2009